We could all use some extra cash on hand, and this dividend stock could create loads of it. The post Invest $15,000, Create ...

IGM Financial Inc. (TSE:IGM – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six research ...

IGM Financial Inc. (OTCMKTS:IGIFF – Get Free Report) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 691,700 shares, an ...

Detailed price information for North American Tech Ishares ETF (IGM-A) from The Globe and Mail including charting and trades.

Detailed price information for North American Tech Ishares ETF (IGM-A) from The Globe and Mail including charting and trades.

Fintel reports that on January 13, 2025, JP Morgan upgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from ...

On Friday, IGM Biosciences Inc (IGMS) stock saw a decline, ending the day at $2.09 which represents a decrease of $-4.11 or -66.29% from the prior close of $6.2. The stock opened at $2.01 and touched ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

For deeper insights into IGM Biosciences' financial health and future prospects, investors can access comprehensive analysis and 10+ additional ProTips through InvestingPro's detailed research reports ...

InvestingPro subscribers have access to 10 additional key insights and a comprehensive Pro Research Report that provides deeper analysis of IGM Biosciences' financial health and future prospects. In ...

IGM Biosciences has halted all oncology programs and faces a significant pipeline upheaval. Read why I maintain my Sell rating on IGMS stock.